The 2022 ASMBS/IFSO guidelines state that metabolic and bariatric surgery has extensive evidence for safety, efficacy, and durability, with overall long-term outcomes often exceeding 60% excess weight loss
GHRP-2 eleva prolactina y cortisol significativamente
Suppression of prostate cancer metastasis by DPYSL3-targeted saRNA
A large real-world study shows that patients who stop popular GLP-1based weight-loss drugs often return to treatment or try alternative therapies, helping explain why average weight regain after discontinuation may be smaller than expected
Many were eventually pulled from the market after evidence of serious adverse effects, including increased rates of cardiovascular events, heart attack and stroke, and psychiatric effects such as mood changes, depression, anxiety and suicidal thoughts
However, these drugs have side effects, including gastrointestinal upset and nausea